跳至主要内容
临床试验/NCT00762970
NCT00762970已完成不适用

Controlling Myopia Progression With Soft Contact Lenses

Johnson & Johnson Vision Care, Inc.1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2007年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
1
主要终点
Spherical Equivalent Refraction

研究概览

简要总结

This study is to investigate whether novel soft contact lens optical designs can slow myopia progression.

详细描述

The study will be a prospective, randomized, single blind, bilateral dispensing study

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
8 Years 至 12 Years(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Myopic subjects between 8 and 12 years of age.
  • •The subject best sphere contact lens correction must lie between -0.75D (best of the two eyes) and -5.00D (worst of the two eyes)
  • •Astigmatism must be less than or equal to 1.00D
  • •1.00D or less difference in spherical equivalent between the two eyes
  • •The subject must have a best-corrected visual acuity of 0.8+2 (20/25+2) and spherical equivalent refraction visual acuity of 0.820/25) or better in both eyes
  • •The subject must have at least 8D of accommodation
  • •The subject and subject's parent or legal guardian must read and sign the STAEMENT OF INFORMED CONSENT
  • •The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.

排除标准

  • •Any ocular or systemic allergies or diseases that may interfere with contact lens wear.
  • •Systemic disease or autoimmune disease or use of medication (e.g. antihistamine), which may interfere with lens wear.
  • •Clinically significant (grade 3 or 4)corneal edema, corneal vascularization, corneal staining, or any other abnormality of the cornea, which may contraindicate contact lens wear.
  • •Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection that might interfere with contact lens wear.
  • •Any ocular infection.
  • •Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
  • •Any infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g. HIV)
  • •Anisometropia of greater than 1.00D
  • •Astigmatism of greater than 1.00D in either eye
  • •Eye injury or surgery within eight weeks immediately prior to enrollment for this study.
  • •Pervious refractive surgery, rigi contact lens wear, orthokeratology, keratconus or other corneal irregularity in either eye.
  • •Strabismus in either eye
  • •Pupil orr lid abnormality or infection in either eye
  • •Central corneal scar in either eye
  • •Aphakia in either eye
  • •Contraindications to contact lens wear such as dry eye or history of prior unsuccessful contact lens wear.
  • •History of participation in prior clinical trials aimed to control myopia progression
  • •Surgically altered eyes, ocular infection of any type, ocular inflammation
  • •Subject has anterior chamber angle grade 2 or narrower

研究组 & 干预措施

Test Lens 1

Experimental

Investigational soft contact lenses worn daily.

干预措施: Test Lens 1 (Device)

Test Lens 2

Experimental

Investigational soft contact lenses worn daily.

干预措施: Test Lens 2 (Device)

Control lens

Active Comparator

Spectacle lenses worn daily.

干预措施: Control Lens (Device)

结局指标

主要结局

Spherical Equivalent Refraction

时间窗: Baseline and every 6 months post-baseline for 2 years

Spherical equivalent refraction was computed from the sphero-cylindrical refraction measured with an open-field auto refractor (WAM-5500) and descriptively summarized for each follow-up. Higher spherical refraction indicates progression in Myopia.

Axial Length (Axial Elongation)

时间窗: Baseline and every 6 months post-baseline for 2 years

Axial length was measured with the IOLMaster at baseline and every 6 months post-baseline for 2 years. Axial length was descriptively summarized for each follow-up.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验